Senate Democratic Leader Chuck Schumer made clear that on drug pricing reform “our first goal is [the house bill]. Period.”

The chart below demonstrates why Senator Schumer is right: H.R. 3 is the only bill that truly reduces costs for both patients and taxpayers by giving Medicare the power to negotiate for lower prices and is the only meaningful way to put an end to the power of the big drug companies. Nearly 9 in 10 Americans, including 85 percent of Republicans, support Medicare negotiation.